Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new study-record version dated November 2, 2026, was added, documenting a change to the study status; the page’s last-update date is November 3, 2026.SummaryDifference0.1%

- Check16 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check23 days agoChange DetectedA sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check37 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check51 days agoChange DetectedNew history entries add updated Study Status and Contacts/Locations for the trial, with changes dated 2026-09-24 and 2026-09-25. An entry dated 2026-08-28 has been removed.SummaryDifference0.2%

Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.